Is the occurrence of a fragility fracture - where Medicare beneficiaries broke a hip, wrist or shoulder - a missed opportunity to reduce exposure to prescription drugs associated with fracture risk?
Jeffrey C. Munson, M.D., M.S.C.E., of the Geisel School of Medicine at Dartmouth, Lebanon, N.H., and coauthors tried to answer that question in an article published online by JAMA Internal Medicine.